Incidence of cholinergic and memantine treatment in Alzheimer's disease in Finland.
Virta
Lauri
L
Viramo
Petteri
P
D000328:Adult; D000367:Age Factors; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy / Q000453:epidemiology*; D018678:Cholinergic Agents / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000627:therapeutic use*; D004363:Drug Utilization / Q000706:statistics & numerical data; D005260:Female; D005387:Finland; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000706:statistics & numerical data; D008297:Male; D008559:Memantine / Q000627:therapeutic use*; D008875:Middle Aged; D009313:National Health Programs / Q000706:statistics & numerical data; D018697:Nootropic Agents / Q000627:therapeutic use*; D012042:Registries; D012737:Sex Factors
D018678:Cholinergic Agents; D015259:Dopamine Agents; D018697:Nootropic Agents; D008559:Memantine